Biotech ETFs Face Crucial FDA Week as Drug Catalysts Loom - State Street SPDR S&P Biotech ETF (ARCA:XBI)
XBI and IBB lagged SPY and QQQ as two FDA decisions and fresh Alzheimer's and obesity-drug data put biotech ETFs in focus.

What's Your Reaction?









